NYSE trade advice (A): US Healthcare stock | 4-6% target | USA stock trading signal on 19 May 2026

Date

May 19, 2026

Analysed By

Naranj Capital Research Desk

Stock Market

NYSE, United States of America

top 10-12 trading advice/month
trade holding period 1-2 weeks
average profit 5-10% per trade
and other exclusive benefits...

Subscribe Premium Advice

Already a subscriber? Sign In

Short Term Stock Trading Advice in USA

Buy

Buy
Range

Target

Stoploss

Upside
Potential

Trade
Duration

Oscar Health

24 - 25

26 - 27

Below 22.5

4% – 6%

12 - 14 Days

4% – 6%

12 - 14 Days

Buy

Oscar Health

Buy
Range

24 - 25

Target

26 - 27

Stoploss

Below 22.5

Upside
Potential

4% – 6%

Trade
Duration

12 - 14 Days

4% – 6%

12 - 14 Days

* Once the first target hit, reset the StopLoss at your buying price.

Oscar Health (NYSE: OSCR) - Stock Overview

NYSE

Stock Name

Sector

52 Weeks High

52 Weeks Low

OSCR

Oscar Health

Health Care

25.58

10.69

NYSE OSCR

Stock Name Oscar Health

Sector Health Care

52 Weeks High 25.58

52 Weeks Low 10.69

Oscar Health (NYSE: OSCR) - Q1 FY26 Financials Highlights

Metric	Q1 FY26 (Mar '26)	Q4 FY25 (Dec '25)	Q1 FY25 (Mar '25)	QoQ Change	YoY Change
Total Revenue	$4,647 M	$2,805 M	$3,046 M	▲ 65.7%	▲ 52.6%
Adjusted EBITDA	$727.1 M	$(307.8) M	$328.8 M	▲ N/M (turnaround)	▲ 121.1%
Operating Margin	15.20%	-11.90%	9.80%	▲ 2,710 bps	▲ 540 bps
Net Income (PAT)	$679.0 M	$(352.6) M	$275.3 M	▲ N/M (turnaround)	▲ 146.6%
Diluted EPS	$2.07	$(1.24)	$0.92	▲ N/M (turnaround)	▲ 125.0%

Oscar Health (NYSE: OSCR) - Earnings Call Summary for Q1/2026

Revenue & members jumped sharply: Revenue grew 53% YoY to $4.6 billion, with members rising 56% YoY to 3.2 million, driven by strong open enrollment and retention.
Record profit quarter: Net income hit an all-time high of $679 million ($2.07 EPS), beating estimates by a wide margin. Adjusted EBITDA also nearly tripled YoY.
Margins expanded nicely: Medical loss ratio improved to 70.5%, a 490 bps improvement YoY, helped by smart pricing and disciplined cost control. SG&A ratio also improved.
Tech & AI driving efficiency: Management highlighted technology, AI initiatives, and their new "Lucie" product as key levers improving operations and member experience.
Outlook reaffirmed: Full-year 2026 revenue guidance maintained at $18.7B to $19B, with company on track for meaningful profitability. Strong cash position of $8.1 billion gives flexibility for future growth.

Oscar Health (NYSE: OSCR) vs NYSE - Relative Performance

The image showcases Oscar Health's 1-year performance relative to NYSE. — Relative Performance - Last 1 Year
OSCR — NYSE —

Oscar Health (NYSE: OSCR) - Price Performance

Oscar Health (NYSE: OSCR) - Technical Analysis (Daily)

The stock had been in a deep consolidation phase and has now given a fresh breakout above the resistance zone.
If the price manages to sustain above this level, an upside move is likely in the near term.

Oscar Health (NYSE: OSCR) - Oscillators

EMA	Value	Stock Position
5 EMA	23.63	Above
10 EMA	22.35	Above
20 EMA	20.24	Above
50 EMA	17.53	Above
100 EMA	16.43	Above
200 EMA	16.00	Above

Oscar Health (NYSE: OSCR) - Exponential Moving Averages (EMAs)

EMA	Value	Stock Position
5 EMA	23.63	Above
10 EMA	22.35	Above
20 EMA	20.24	Above
50 EMA	17.53	Above
100 EMA	16.43	Above
200 EMA	16.00	Above

Conclusion - Oscar Health (NYSE: OSCR) Stock Price Forecast

Based on our positional trading picks in USA stocks, Oscar Health stock price target will be USD 26 - USD 27 in the next 12-14 trading sessions.

Share with

0 0 votes

Article Rating

0 Comments

top 10-12 trading advice/month
trade holding period 1-2 weeks
average profit 5-10% per trade
and other exclusive benefits...

Subscribe Premium Advice

Already a subscriber? Sign In

Short Term Stock Trading Advice in USA

Buy

Buy
Range

Target

Stoploss

Upside
Potential

Trade
Duration

Oscar Health

24 - 25

26 - 27

Below 22.5

4% – 6%

12 - 14 Days

Buy Oscar Health

Buy
Range 24 - 25

Target 26 - 27

Stoploss Below 22.5

Upside
Potential 4% – 6%

Trade
Duration 12 - 14 Days

Buy

Buy
Range

Target

Stoploss

Upside
Potential

Trade
Duration

Oscar Health

24 - 25

26 - 27

Below 22.5

4% – 6%

12 - 14 Days

4% – 6%

12 - 14 Days

Buy

Oscar Health

Buy
Range

24 - 25

Target

26 - 27

Stoploss

Below 22.5

Upside
Potential

4% – 6%

Trade
Duration

12 - 14 Days

4% – 6%

12 - 14 Days

* Once the first target hit, reset the StopLoss at your buying price.

* Trade durations are approximate; actual holding period may vary.

Oscar Health (NYSE: OSCR) - Stock Overview

NYSE

Stock Name

Sector

52 Weeks High

52 Weeks Low

OSCR

Oscar Health

Health Care

25.58

10.69

NYSE OSCR

Stock Name Oscar Health

Sector Health Care

52 Weeks High 25.58

52 Weeks Low 10.69

Company profile

Oscar Health, Inc. is a U.S.-based healthcare technology company that provides health insurance plans for individuals, families, employees, and small businesses. It also offers technology platforms, provider engagement tools, reinsurance products, and online enrollment services for brokers and customers. Founded in 2012, the company is headquartered in New York.

Oscar Health (NYSE: OSCR) - Q1 FY26 Financials Highlights

Metric	Q1 FY26 (Mar '26)	Q4 FY25 (Dec '25)	Q1 FY25 (Mar '25)	QoQ Change	YoY Change
Total Revenue	$4,647 M	$2,805 M	$3,046 M	▲ 65.7%	▲ 52.6%
Adjusted EBITDA	$727.1 M	$(307.8) M	$328.8 M	▲ N/M (turnaround)	▲ 121.1%
Operating Margin	15.20%	-11.90%	9.80%	▲ 2,710 bps	▲ 540 bps
Net Income (PAT)	$679.0 M	$(352.6) M	$275.3 M	▲ N/M (turnaround)	▲ 146.6%
Diluted EPS	$2.07	$(1.24)	$0.92	▲ N/M (turnaround)	▲ 125.0%

Oscar Health (NYSE: OSCR) - Earnings Call Summary for Q1/2026

Revenue & members jumped sharply: Revenue grew 53% YoY to $4.6 billion, with members rising 56% YoY to 3.2 million, driven by strong open enrollment and retention.
Record profit quarter: Net income hit an all-time high of $679 million ($2.07 EPS), beating estimates by a wide margin. Adjusted EBITDA also nearly tripled YoY.
Margins expanded nicely: Medical loss ratio improved to 70.5%, a 490 bps improvement YoY, helped by smart pricing and disciplined cost control. SG&A ratio also improved.
Tech & AI driving efficiency: Management highlighted technology, AI initiatives, and their new "Lucie" product as key levers improving operations and member experience.
Outlook reaffirmed: Full-year 2026 revenue guidance maintained at $18.7B to $19B, with company on track for meaningful profitability. Strong cash position of $8.1 billion gives flexibility for future growth.

Oscar Health (NYSE: OSCR) vs NYSE - Relative Performance

Oscar Health (NYSE: OSCR) - Price Performance

Oscar Health (NYSE: OSCR) - Technical Analysis (Daily)

The stock had been in a deep consolidation phase and has now given a fresh breakout above the resistance zone.
If the price manages to sustain above this level, an upside move is likely in the near term.

Oscar Health (NYSE: OSCR) - Oscillators

EMA	Value	Stock Position
5 EMA	23.63	Above
10 EMA	22.35	Above
20 EMA	20.24	Above
50 EMA	17.53	Above
100 EMA	16.43	Above
200 EMA	16.00	Above

Oscar Health (NYSE: OSCR) - Exponential Moving Averages (EMAs)

EMA	Value	Stock Position
5 EMA	23.63	Above
10 EMA	22.35	Above
20 EMA	20.24	Above
50 EMA	17.53	Above
100 EMA	16.43	Above
200 EMA	16.00	Above

Conclusion - Oscar Health (NYSE: OSCR) Stock Price Forecast

Based on our positional trading picks in USA stocks, Oscar Health stock price target will be USD 26 - USD 27 in the next 12-14 trading sessions.

0 0 votes

Article Rating

0 Comments